Itron (NASDAQ:ITRI) SVP Christopher Ware Sells 195 Shares of Stock

Itron, Inc. (NASDAQ:ITRI) SVP Christopher Ware sold 195 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $97.83, for a total value of $19,076.85. Following the sale, the senior vice president owned 30,116 shares of the company’s stock, valued at $2,946,248.28. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Performance

NASDAQ:ITRI traded down $0.91 during midday trading on Monday, reaching $99.12. The stock had a trading volume of 34,560 shares, compared to its average volume of 879,535. The company has a quick ratio of 2.29, a current ratio of 2.75 and a debt-to-equity ratio of 0.96. The stock has a market cap of $4.34 billion, a P/E ratio of 16.55, a P/E/G ratio of 1.20 and a beta of 1.30. The firm has a fifty day simple moving average of $90.52 and a two-hundred day simple moving average of $90.11. Itron, Inc. has a 12-month low of $77.77 and a 12-month high of $142.00.

Itron (NASDAQ:ITRI) last released its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.29 by $0.30. The company had revenue of $562.90 million during the quarter, compared to analysts’ expectations of $566.34 million. Itron had a net margin of 11.90% and a return on equity of 19.26%. The business’s revenue was down 7.2% on a year-over-year basis. During the same quarter last year, the business earned $1.62 EPS. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. On average, equities analysts expect that Itron, Inc. will post 6.4 EPS for the current year.

Hedge Funds Weigh In On Itron

Several large investors have recently added to or reduced their stakes in ITRI. Capital World Investors purchased a new position in Itron in the 4th quarter valued at about $10,460,000. Assenagon Asset Management S.A. raised its position in shares of Itron by 160.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 336,710 shares of the scientific and technical instruments company’s stock valued at $29,136,000 after purchasing an additional 207,416 shares in the last quarter. DNB Asset Management AS acquired a new position in shares of Itron in the 4th quarter valued at approximately $12,191,000. WINTON GROUP Ltd purchased a new position in shares of Itron during the 4th quarter valued at approximately $5,795,000. Finally, Fieldview Capital Management LLC boosted its stake in shares of Itron by 54.1% during the 4th quarter. Fieldview Capital Management LLC now owns 40,095 shares of the scientific and technical instruments company’s stock valued at $3,723,000 after buying an additional 14,079 shares during the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ITRI has been the subject of a number of analyst reports. Stephens reissued an “overweight” rating and set a $130.00 target price on shares of Itron in a research note on Wednesday, May 20th. Roth Capital reaffirmed a “buy” rating and set a $136.00 price objective on shares of Itron in a report on Wednesday, April 29th. Needham & Company LLC increased their price objective on Itron from $116.00 to $128.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Robert W. Baird set a $125.00 target price on Itron in a report on Wednesday, July 29th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a research note on Wednesday, August 5th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $131.33.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.